About Company
- Legal Name: Cadchem Laboratories Ltd
- Registered country: India
- Address: Plot no 1060, Industrial Area, Phase 2,, Chandigarh
- Number of employees: 100 - 249
- Established year: 1995
Description:
Cadchem Laboratories is an API manufacturing company holding Korean MFDS and WHO-GMP approvals, with a focus on cardiovascular, neurological and anti-diabetic segments for global markets. The company holds CEPs for clopidogrel bisulphate Form II and levetiracetam, with additional CEP filings planned for rosuvastatin calcium, rifaximin and brivaracetam, alongside current manufacturing of citicoline sodium, benfotiamine and rivaroxaban, and future plans for ticagrelor, quetiapine, apixaban, empagliflozin, dapagliflozin and ketorolac tromethamine.
Business Activities
Active Pharmaceutical Ingredients (APIs)
ManufacturerAPI Manufacturer
Pharma Chemicals
ManufacturerAPI Manufacturer
Innovator APIs
ManufacturerAPI Manufacturer
Key Products/Services
- Active Pharmaceutical Ingredients (APIs): Active Pharmaceutical Ingredients (APIs), Cardiovascular API, Neurology APIs, Anti-diabetic APIs
- Pharma Chemicals: API & INTERMEDIATES
- Innovator APIs: Rosuvastatin Calcium, Levetiracetam, Strontium Ranelate, Clopidogrel Bisulphate, Rifaximin, Citicoline Sodium
Our Products & Services
Certifications
Proofs
CPHI India 2026
11/2026 – 11/2026
CPHI India 2026
Ratings
(0)
(0)
(0)
(0)
(0)
Comments
Filters:
Sort by:
No comments available.
Leave your rating & comment